Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiagent chemopreventive agent combinations.

D E Brenner1

  • 1Cancer and Geriatrics Center, University of Michigan Medical Center, Ann Arbor 48109-0934, USA. dbrenner@umich.edu

Journal of Cellular Biochemistry. Supplement
|April 13, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low Prevalence of Screen-Detected Colorectal Cancer in an Average-Risk Population: The New Normal.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2021
Same author

A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer.

Cancer chemotherapy and pharmacology·2013
Same author

Cancer chemoprevention.

Current opinion in gastroenterology·2006
Same author

Cancer chemoprevention: lessons learned and future directions.

British journal of cancer·2005
Same author

New paradigms in oncological therapeutics: redefining combination chemotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2002
Same author

Expression of 12-lipoxygenase as a biomarker for melanoma carcinogenesis.

Melanoma research·2002
Same journal

Understanding immune cell trafficking patterns via in vivo bioluminescence imaging.

Journal of cellular biochemistry. Supplement·2003
Same journal

In vivo molecular imaging.

Journal of cellular biochemistry. Supplement·2003
Same journal

Introduction to the physics of molecular imaging with radioactive tracers in small animals.

Journal of cellular biochemistry. Supplement·2003
Same journal

Can small animal imaging accelerate drug development?

Journal of cellular biochemistry. Supplement·2003
Same journal

Advances in molecular labeling, high throughput imaging and machine intelligence portend powerful functional cellular biochemistry tools.

Journal of cellular biochemistry. Supplement·2003
Same journal

Grappling with metastatic risk: bringing molecular imaging of Met expression toward clinical use.

Journal of cellular biochemistry. Supplement·2003
See all related articles

Dietary components like beta-carotene and vitamin E show promise in cancer chemoprevention. Combining agents and testing them through preclinical and clinical trials is key to developing effective cancer prevention strategies.

Area of Science:

  • Oncology
  • Nutritional Science
  • Preventive Medicine

Background:

  • Epidemiologic studies suggest dietary factors (beta-carotene, vitamin E, calcium, selenium) may inhibit carcinogenesis.
  • Elucidation of molecular mechanisms strengthens the rationale for combining chemopreventive agents targeting multiple pathways.

Purpose of the Study:

  • To outline a systematic approach for identifying synergistic chemoprevention agent combinations.
  • To detail the preclinical and clinical trial phases necessary for validating these combinations.

Main Methods:

  • Preclinical in vitro development of potential synergistic combinations.
  • Testing in animal models of carcinogenesis with biochemical, molecular, and pathological assessments.
  • Phase I trials for dose determination and Phase II trials for efficacy assessment in humans.

Related Experiment Videos

Main Results:

  • The abstract does not contain specific results but outlines a methodology for achieving them.
  • The proposed methodology integrates in vitro, animal, and human studies.

Conclusions:

  • A systematic preclinical and clinical development process is essential for identifying and validating effective chemoprevention strategies.
  • Combining agents targeting multiple carcinogenesis pathways offers a promising approach to cancer prevention.